EUVIMEDEUVIMED entdecken
Crossref

FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD

Ya-Chin Huang, Chih-Wen Wang iD, Jiun-Chi Huang iD, Po-Cheng Liang, Ming-Lun Yeh iD, Yi-Yu Chen, Yi-Hung Lin, Tyng-Yuan Jang iD, Yu-Ju Wei, Ming-Yen Hsieh, Chao-Kuan Huang, Hsu-Han Chien und 7 weitere

Journal of Gastroenterology and Hepatology · 2026-01 · 41 (1) · 332-340

DOI: 10.1111/jgh.70162 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 21.11.2025. Verfasst von Ya-Chin Huang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Kaohsiung Medical University Gangshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Coronary Artery Disease, Vascular Calcification, Fatty Liver, Referral and Consultation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Kaohsiung Medical University, National Sun Yat-sen University, Kaohsiung Medical University Gangshan Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims The association between metabolic dysfunction‐associated steatotic liver disease (MASLD), liver fibrosis, and coronary artery calcification (CAC) remains uncertain. We investigated their relationships and the predictive role of the Fibrosis‐4 (FIB‐4) index.

Methods

The study included 6058 subjects undergoing health check‐ups and coronary computed tomography. Steatotic liver disease (SLD) was identified via ultrasonography or hepatic steatosis index > 36. MASLD was defined as SLD with at least one of the five cardiometabolic risk factors. Liver fibrosis severity was assessed using the FIB‐4 index to assess its association with CAC and predictive performance at different CAC thresholds.

Results

MASLD was present in 39.8% of participants, with a higher CAC prevalence than non‐MASLD individuals (51.1% vs. 42.5%, p < 0.001). Factors associated with the presence of CAC included age (odds ratio [OR]/95% confidence intervals [CI]: 1.117/1.106–1.128, p < 0.001), male gender (OR/95% CI: 4.448/3.660–5.406, p < 0.001), MASLD (OR/95% CI: 1.570/1.342–1.837, p < 0.001), and FIB‐4 (OR/95% CI: 1.217/1.034–1.433, p = 0.018). Among MASLD subjects, the prevalence of CAC increased with FIB‐4 value and cardiometabolic burdens. FIB‐4 values increased progressively in patients with higher coronary artery calcium scores ( p ‐trend < 0.001). A FIB‐4 cut‐off of ≥ 2.67 provided the highest positive predictive value (89.7%) for the presence of CAC, while a cut‐off of 1.26 offered the best negative predictive value (95.1%) for severe CAC.

Conclusion

MASLD patients with elevated FIB‐4 are at increased risk of coronary atherosclerosis. Incorporating FIB‐4 into routine assessment may help identify high‐risk individuals who could benefit from early cardiology referral and preventive cardiovascular care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseaseVascular CalcificationFatty LiverReferral and ConsultationLiver CirrhosisHumansMaleFemaleMiddle AgedSeverity of Illness IndexPrevalenceAgedPredictive Value of TestsAdultRisk Factors

Stichwörter der Autor:innen

FIB‐4MASLDcardiovascular risk stratificationscoronary artery calcification

Autor:innen und Institutionen

  • Department of Preventive Medicine, Kaohsiung Medical University Gangshan Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Occupational & Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Doctoral Program of Clinical and Experimental Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • School of Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung, Taiwan.
  • Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Chih-Wen Wang, Jiun-Chi Huang, Ming-Lun Yeh, Tyng-Yuan Jang, Jee-Fu Huang, Chung-Feng Huang, Ming-Lung Yu

Förderung

  • Kaohsiung Medical University
  • National Sun Yat-sen University
  • Kaohsiung Medical University Gangshan Hospital
  • Ministry of Education (MOE)

Zitieren

APA

Huang, Y. C., Wang, C. W., Huang, J. C., Liang, P. C., Yeh, M. L., Chen, Y. Y., Lin, Y. H., Jang, T. Y., Wei, Y. J., Hsieh, M. Y., Huang, C. K., Chien, H. H., Wu, C. J., Huang, J. F., Dai, C. Y., Chuang, W. L., Lin, C. I., Huang, C. F., & Yu, M. L. (2026). FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD. Journal of Gastroenterology and Hepatology, 41(1), 332-340. https://doi.org/10.1111/jgh.70162

Vancouver

Huang YC, Wang CW, Huang JC, Liang PC, Yeh ML, Chen YY, et al. FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD. Journal of Gastroenterology and Hepatology. 2026;41(1):332-340. doi:10.1111/jgh.70162

BibTeX
@article{Huang2026,
  author = {Huang, Ya-Chin and Wang, Chih-Wen and Huang, Jiun-Chi and Liang, Po-Cheng and Yeh, Ming-Lun and Chen, Yi-Yu and Lin, Yi-Hung and Jang, Tyng-Yuan and Wei, Yu-Ju and Hsieh, Ming-Yen and Huang, Chao-Kuan and Chien, Hsu-Han and Wu, Chia-Jen and Huang, Jee-Fu and Dai, Chia-Yen and Chuang, Wan-Long and Lin, Chia-I and Huang, Chung-Feng and Yu, Ming-Lung},
  title = {FIB‐4 Serves as a Referral Index for Coronary Artery Calcification in Patients With MASLD},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {1},
  pages = {332--340},
  doi = {10.1111/jgh.70162}
}
Kostenlos starten →